21.1408.24% ( +1.610 )
Delay Trading: Nov 18, 11:05:21News
Biotech Approvals and Energy Contracts Fuel Hong Kong Small-Cap Momentum
Global Report·- Hong Kong stocks saw a collective recovery across multiple sub-sectors driven by favorable fundamental data and capital inflows. - Key catalysts included Everest Medicines securing a May drug approval, Shanghai Electric Wind Power winning a 1 billion yuan offshore wind order, and robust financial results from companies like Akeso and Fudan Microelectronics. - Additional performance growth was observed in education, digital healthcare, insurance, property management, and energy sectors due to policy benefits and business recovery.
